ページの先頭です

研究業績

ここから原著論文1.原著論文(2003年以降)

    -2017-
  1. Yoshiki Yasukochi, Jun Sakuma, Ichiro Takeuchi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Yoshiji Yamada.
    Longitudinal exome-wide association study to identify genetic susceptibility loci for hypertension in a Japanese population.
    Exp Mol Med 2017;49:e409.

  2. Chikara Ueyama, Hideki Horibe, Yuichiro Yamase, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada.
    Associations of smoking with the prevalence of common complex diseases and metabolic parameters in community-dwelling Japanese individuals.
    Biomed Rep 2017;7:429-438.

  3. Kumpei Tanisawa, Nobuyoshi Hirose, Yasumichi Arai, Hiroshi Shimokata, Yoshiji Yamada, Hisashi Kawai, Motonaga Kojima, Shuichi Obuchi, Hirohiko Hirano, Hiroyuki Suzuki, Yoshinori Fujiwara, Kazushige Ihara, Yu Taniguchi, Shoji Shinkai, Maki Sugaya, Mitsuru Higuchi, Tomio Arai, Seijiro Mori, Motoji Sawabe, Noriko Sato, Masaaki Muramatsu, Masashi Tanaka.
    Inverse association between height-increasing alleles and extreme longevity in Japanese women.
    J Gerontol A Biol Sci Med Sci 2018;73:588-595.

  4. Yoshiki Yasukochi, Jun Sakuma, Ichiro Takeuchi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Yoshiji Yamada.
    Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.
    Mol Genet Genomics 2018;293:371-379.

  5. Yoshiji Yamada, Hideki Horibe, Mitsutoshi Oguri, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Motoji Sawabe.
    Identification of novel hyper- and hypo-methylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study.
    Int J Mol Med 2018;41:2724-2732.

  6. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of five genetic variants as novel determinants of type 2 diabetes mellitus in Japanese individuals by exome-wide association studies.
    Oncotarget 2017;8:80492-80505.

  7. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of TNFSF13, SPATC1L, SLC22A25, and SALL4 as novel susceptibility loci for atrial fibrillation in Japanese individuals by an exome-wide association study.
    Mol Med Rep 2017;16:5823-5832.

  8. Sariya Dechamethakun, Noriko Sato, Shinobu Ikeda, Motoji Sawabe, Seijiro Mori, Yoshiji Yamada, Masashi Tanaka, Masaaki Muramatsu, Tomio Arai.
    Association of Macrophage Capping Protein (CAPG) Arg335His Polymorphism and Cancer Susceptibility in the Elderly Japanese.
    J Gerontol Geriatr Res 2017 2017;6:1000417.

  9. Yoshiji Yamada,Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of polymorphisms in 12q24.1, ACAD10, and BRAP as novel genetic determinants of blood pressure in Japanese by exome-wide association studies.
    Oncotarget 2017;8:43068-43079.

  10. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of eight genetic variants as novel determinants for dyslipidemia in Japanese by exome-wide association studies.
    Oncotarget 2017;8:38950-38961.

  11. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of STXBP2 as a novel susceptibility locus for myocardial infarction in Japanese individuals by an exome-wide association study.
    Oncotarget 2017;8:33527-33535.

  12. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of C21orf59 and ATG2A as novel determinants of renal function-related traits in Japanese by exome-wide association studies.
    Oncotarget 2017;8:45259-45273.

  13. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of rs7350481 at chromosome 11q23.3 as a novel determinant of metabolic syndrome in Japanese individuals by exome-wide association studies.
    Oncotarget 2017;8:39296-39308.

  14. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of EGFLAM, SPATC1L, and RNASE13 as novel susceptibility loci for aortic aneurysm in Japanese individuals by exome-wide association studies.
    Int J Mol Med 2017;39:1091-1100.

  15. Yoshiji Yamada, Jun Sakuma, Ichiro Takeuchi, Yoshiki Yasukochi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Masaaki Muramatsu, Motoji Sawabe, Yoshinori Fujiwara, Yu Taniguchi, Shuichi Obuchi, Hisashi Kawai, Shoji Shinkai, Seijiro Mori, Tomio Arai, Masashi Tanaka.
    Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies.
    Int J Mol Med 2017;39:1477-1491.

  16. Takuya Sumi, Mitsutishi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Kota Matsui, Ichiro Takeuchi, Toyoaki Murohara, Yoshiji Yamada.
    Association of renal function with clinical parameters and conditions in a longitudinal population-based epidemiological stidy.
    Biomed Rep 2017;6:242-250.

  17. John M. Gregson, Daniel Freitag, Praveen Surendran, Nathan O. Stitziel, Rajiv Chowdhury, Stephen Burgess, Stephen Kaptoge, Pei Gao, James R. Staley, Peter Willeit, Sune Nielsen, Muriel Caslake, Stella Trompet, Linda M. Polfus, Kari Kuulasmaa, Jukka Kontto, Markus Perola, Stefan Blankenberg, Giovanni Veronesi, Francesco Gianfagna, Satu Mannisto, Akinori Kimura, Honghuang Lin, Dermot F. Reilly, Mathias Gorski, Vladan Mijatovic; CKDGen consortium, Patricia Munroe, Georg Ehret; International Consortium for Blood Pressure, Alex Thompson, Maria Uria-Nickelsen, Anders Malarstig, Abbas Dehghan; CHARGE inflammation working group, Thomas F. Vogt, Taishi Sasaoka, Fumihiko Takeuchi, Norihiro Kato, Yoshiji Yamada, Frank Kee Martina Muller-Nurasyid, Jean Ferrieres, Dominique Arveiler, Philippe Amouyel, Veikko Salomaa, Eric Boerwinkle, Simon G. Thompson, Ian Ford, J. Wouter Jukema, Naveed Sattar, Chris Packard, Abdulla al Shafi Majumder, Dewan S. Alam, Panos Deloukas, Heribert Schunkert, Nilesh Samani, Sekar Kathiresan; MICAD Exome consortium, Borge G. Nordestgaard, Danish Saleheen, Joanna M. M. Howson, Emanuele Di Angelantonio, Adam Butterworth, John Danesh; EPIC-CVD consortium and the CHD Exome+ consortium.
    Genetic invalidation of Lp-PLA2 as a therapeutic target: large-scale study of five functional Lp-PLA2 lowering alleles.
    Eur J Prev Cardiol 2017;24:492-504.

  18. -2016-
  19. Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Kota Matsui, Ichiro Takeuchi, Yoshiji Yamada.
    Obesity-related changes in clinical parameters and conditions in a longitudinal population-based epidemiological study.
    Obes Res Clin Pract 2017;11:299-314.

  20. Saeko Tada-Oikawa, Gaku Ichihara, Hitomi Fukatsu, Yuka Shimanuki, Natsuki Tanaka, Yuka Suzuki, Masahiko Murakami, Kiyora Izuoka, Jie Chang, Wenting Wu, Yoshiji Yamada, Sahoko Ichihara.
    Titanium dioxide particle type and concentration influence the inflammatory response in a model of human intestinal tract.
    Int J Mol Sci 2016;17:576.

  21. Tamotsu Nishida, Yoshiji Yamada.
    SUMOylation of the KRAB zinc-finger transcription factor PARIS/ZNF746 regulates its transcriptional activity.
    Biochem Bioiphys Res Commun 2016;473:1261-1267.

  22. Kumpei Tanisawa, Yasumichi Arai, Nobuyoshi Hirose, Hiroshi Shimokata, Yoshiji Yamada, Hisashi Kawai, Motonaga Kojima, Shuichi Obuchi, Hirohiko Hirano, Hideyo Yoshida, Hiroyuki Suzuki, Yoshinori Fujiwara, Kazushige Ihara, Maki Sugaya, Tomio Arai, Seijiro Mori, Motoji Sawabe, Noriko Sato, Masaaki Muramatsu, Mitsuru Higuchi, Yao-Wen Liu, Qing-Peng Kong, Masashi Tanaka.
    Exome-wide association study identifies CLEC3B missense variant p.S106G as being associated with extreme longevity in East Asian populations.
    J Gerontol A Biol Sci Med Sci 2017;72:309-318.

  23. Yuichiro Yamase, Kimihiko Kato, Hideki Horibe, Chikara Ueyama, Tetsuo Fujimaki, Mitsutoshi Oguri, Masazumi Arai, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of genetic variants with atrial fibrillation.
    Biomed Rep 2016;4;178-182.

  24. Traylor M, Zhang CR, Adib-Samii P, Devan WJ, Parsons OE, Lanfranconi S, Gregory S, Cloonan L, Falcone GJ, Radmanesh F, Fitzpatrick K, Kanakis A, Barrick TR, Moynihan B, Lewis CM, Boncoraglio GB, Lemmens R, Thijs V, Sudlow C, Wardlaw J, Rothwell PM, Meschia JF, Worrall BB, Levi C, Bevan S, Furie KL, Dichgans M, Rosand J, Markus HS, Rost N, Smoller S, Sorkin J, Wang X, Selim M, Pikula A, Wolf P, Debette S, Seshadri S, de Bakker P, Chasman D, Rexrode K, Chen I, Rotter J, Luke M, Sale M, Lee TH, Chang KC, Elkind M, Goldstein L, James ML, Breteler M, O'Donnell C, Leys D, Carty C, Kidwell C, Olesen J, Sharma P, Rich S, Tatlisumak T, Happola O, Bijlenga P, Soriano C, Giralt E, Roquer J, Jimenez-Conde J, Cotlarcius I, Hardy J, Korostynski M, Boncoraglio G, Ballabio E, Parati E, Mateusz A, Urbanik A, Dziedzic T, Jagiella J, Gasowski J, Wnuk M, Olszanecki R, Pera J, Slowik A, Juchniewicz KJ, Levi C, Nyquist P, Cendes I, Cabral N, Franca P, Goncalves A, Keller L, Crisby M, Kostulas K, Lemmens R, Ahmadi K, Opherk C, Duering M, Dichgans M, Malik R, Gonik M, Staals J, Melander O, Burri P, Sadr-Nabavi A, Romero J, Biffi A, Anderson C, Falcone G, Brouwers B, Rosand J, Rost N, Du R, Kourkoulis C, Battey T, Lubitz S, Mueller-Myhsok B, Meschia J, Brott T, Pare G, Pichler A, Enzinger C, Schmidt H, Schmidt R, Seiler S, Blanton S, Yamada Y, Bersano A, Rundek T, Sacco R, Yvonne Chan YF, Gschwendtner A, Deng Z, Barr T, Gwinn K, Corriveau R, Singleton A, Waddy S, Launer L, Chen C, Le KE, Lee WL, Tan EK, Olugbodi A, Rothwell P, Schilling S, Mok V, Lebedeva E, Jern C, Jood K, Olsson S, Kim H, Lee C, Kilarski L, Markus H, Peycke J, Bevan S, Sheu W, Chiou HY, Chern J, Giraldo E, Taqi M, Jain V, Lam O, Howard G, Woo D, Kittner S, Mitchell B, Cole J, O'Connell J, Milewicz D, Illoh K, Worrall B, Stine C, Karaszewski B, Werring D, Sofat R, Smalley J, Lindgren A, Hansen B, Norrving B, Smith G, Martin JJ, Thijs V, Klijn K, Van't Hof F, Algra A, Macleod M, Perry R, Arnett D, Pezzini A, Padovani A, Cramer S, Fisher M, Saleheen D, Broderick J, Kissela B, Doney A, Sudlow C, Rannikmae K, Silliman S, McDonough C, Walters M, Pedersen A, Nakagawa K, Chang C, Dobbins M, McArdle P, Chang YC, Brown R, Brown D, Holliday E, Kalaria R, Maguire J, Attia J, Farrall M, Giese AK, Fornage M, Majersik J, Cushman M, Keene K, Bennett S, Tirschwell D, Psaty B, Reiner A, Longstreth W, Spence D, Montaner J, Fernandez-Cadenas I, Langefeld C, Bushnell C, Heitsch L, Lee JM, Sheth K.
    Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke.
    Neurology 2016;86:146-153.

  25. Ichihara S, Li W, Omura S, Fujitani Y, Liu Y, Wang Q, Hiraku Y, Hisanaga N, Ding X, Maynard A, Kobayashi T, Ichihara G.
    Exposure assessment and heart rate variability monitoring in workers handling titanium dioxide particles-a pilot study.
    Journal of Nano Research (in press)

  26. -2015-
  27. Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, Kelly TN, Saleheen D, Lehne B, Mateo Leach I, Drong AW, Abbott J, Wahl S, Tan ST, Scott WR, Campanella G, Chadeau-Hyam M, Afzal U, Ahluwalia TS, Bonder MJ, Chen P, Dehghan A, Edwards TL, Esko T, Go MJ, Harris SE, Hartiala J, Kasela S, Kasturiratne A, Khor CC, Kleber ME, Li H, Mok ZY, Nakatochi M, Sapari NS, Saxena R, Stewart AF, Stolk L, Tabara Y, Teh AL, Wu Y, Wu JY, Zhang Y, Aits I, Da Silva Couto Alves A, Das S, Dorajoo R, Hopewell JC, Kim YK, Koivula RW, Luan J, Lyytikainen LP, Nguyen QN, Pereira MA, Postmus I, Raitakari OT, Bryan MS, Scott RA, Sorice R, Tragante V, Traglia M, White J, Yamamoto K, Zhang Y, Adair LS, Ahmed A, Akiyama K, Asif R, Aung T, Barroso I, Bjonnes A, Braun TR, Cai H, Chang LC, Chen CH, Cheng CY, Chong YS, Collins R, Courtney R, Davies G, Delgado G, Do LD, Doevendans PA, Gansevoort RT, Gao YT, Grammer TB, Grarup N, Grewal J, Gu D, Wander GS, Hartikainen AL, Hazen SL, He J, Heng CK, Hixson JE, Hofman A, Hsu C, Huang W, Husemoen LL, Hwang JY, Ichihara S, Igase M, Isono M, Justesen JM, Katsuya T, Kibriya MG, Kim YJ, Kishimoto M, Koh WP, Kohara K, Kumari M, Kwek K, Lee NR, Lee J, Liao J, Lieb W, Liewald DC, Matsubara T, Matsushita Y, Meitinger T, Mihailov E, Milani L, Mills R, Mononen N, Muller-Nurasyid M, Nabika T, Nakashima E, Ng HK, Nikus K, Nutile T, Ohkubo T, Ohnaka K, Parish S, Paternoster L, Peng H, Peters A, Pham ST, Pinidiyapathirage MJ, Rahman M, Rakugi H, Rolandsson O, Rozario MA, Ruggiero D, Sala CF, Sarju R, Shimokawa K, Snieder H, Sparso T, Spiering W, Starr JM, Stott DJ, Stram DO, Sugiyama T, Szymczak S, Tang WH, Tong L, Trompet S, Turjanmaa V, Ueshima H, Uitterlinden AG, Umemura S, Vaarasmaki M, van Dam RM, van Gilst WH, van Veldhuisen DJ, Viikari JS, Waldenberger M, Wang Y, Wang A, Wilson R, Wong TY, Xiang YB, Yamaguchi S, Ye X, Young RD, Young TL, Yuan JM, Zhou X, Asselbergs FW, Ciullo M, Clarke R, Deloukas P, Franke A, Franks PW, Franks S, Friedlander Y, Gross MD, Guo Z, Hansen T, Jarvelin MR, Jorgensen T, Jukema JW, Kahonen M, Kajio H, Kivimaki M, Lee JY, Lehtimaki T, Linneberg A, Miki T, Pedersen O, Samani NJ, Sorensen TI, Takayanagi R, Toniolo D; BIOS-consortium; CARDIo GRAMplusCD; LifeLines Cohort Study; InterAct Consortium, Ahsan H, Allayee H, Chen YT, Danesh J, Deary IJ, Franco OH, Franke L, Heijman BT, Holbrook JD, Isaacs A, Kim BJ, Lin X, Liu J, Marz W, Metspalu A, Mohlke KL, Sanghera DK, Shu XO, van Meurs JB, Vithana E, Wickremasinghe AR, Wijmenga C, Wolffenbuttel BH, Yokota M, Zheng W, Zhu D, Vineis P, Kyrtopoulos SA, Kleinjans JC, McCarthy MI, Soong R, Gieger C, Scott J, Teo YY, He J, Elliott P, Tai ES, van der Harst P, Kooner JS, Chambers JC.
    Trans-ethnic genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.
    Nat Genet 2015;47:1282-1293.

  28. Zhang L, Zong C, Ichihara S, Naito H, Toyokuni S, Kumagai S, Ichihara G.
    A trial to find appropriate animal models of dichloropropane-induced cholangiocarcinoma based on the hepatic distribution of glutathione S-transferases.
    J Occup Health 2015;57:548-554.

  29. Nakatochi M, Ichihara S, Yamamoto K, Ohnaka K, Kato Y, Yokota S, Hirashiki A, Naruse K, Asano H, Izawa H, Matsubara T, Yokota M.
    Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighboring sites.
    Diabetologia 2015;58:2781-2790.

  30. Wen-jie Lu, Yoshiji Yamada, Jun Sakuma.
    Privacy-preserving genome-wide association studies on cloud environment using fully homomorphic encryption.
    BMC Med Inform Decis Mak 2015;15(Suppl 5):S1.

  31. Heying Zhou, Seijiro Mori, Tatsuro Ishizaki, Masashi Tanaka, Kumpei Tanisawa, Makiko Naka-Mieno, Motoji Sawabe, Tomio Arai, Masaaki Muramatsu, Yoshiji Yamada, Hideki Ito.
    Genetic risk score based on the lifetime prevalence of femoral fracture in 924 consecutive autopsies of Japanese males.
    J Bone Miner Metab 2016;34:685-691.

  32. Daisuke Nishizawa, Shinya Kasai, Junko Hasegawa, Naomi Sato, Hidetaka Yamada, Fumihiko Tanioka, Makoto Nagashima, Ryoji Katoh, Yasuo Satoh, Megumi Tagami, Hiroshi Ujike, Norio Ozaki, Toshiya Inada, Nakao Iwata, Ichiro Sora, Masaomi Iyo, Mitsuhiko Yamada, Naoki Kondo, Moo-Jun Won, Nobuya Naruse, Kumi Uehara-Aoyama, Masanari Itokawa, Kazutaka Ohi, Ryota Hashimoto, Kumpei Tanisawa, Tomio Arai, Seijiro Mori, Motoji Sawabe, Makiko Naka-Mieno, Yoshiji Yamada, Miki Yamada, Noriko Sato, Masaaki Muramatsu, Masashi Tanaka, Yoko Irukayama-Tomobe, Yuki C Sato, Takeshi Sakurai, Masakazu Hayashida, Haruhiko Sugimura, Kazutaka Ikeda.
    Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.
    Mol Brain 2015;8:50.

  33. Wenjie Lu, Yoshiji Yamada, Jun Sakuma.
    Efficient secure outsourcing of genome-wide association studies.
    Proceedings of IEEE Security and Privacy Workshop May 21, 2015, p3-6.

  34. David A. duVerles, Shohei Kawasaki, Yoshiji Yamada, Jun Sakuma, Koji Tsuda.
    Privacy-preserving statistical analysis by exact logistic regression.
    Proceedings of IEEE Security and Privacy Workshop May 21, 2015, p7-16.

  35. Yoshiko Murakata, Tetsuo Fujimaki, Yoshiji Yamada.
    Age-related changes in clinical parameters and their relations to common complex diseases.
    Biomed Rep 2015;3:767-777.

  36. Chikara Ueyama, Hideki Horibe, Yuichiro Yamase, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Masazumi Arai, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of polymorphisms of FURIN and ZPR1 with metabolic syndrome.
    Biomed Rep 2015;3:641-647.

  37. Yuichiro Yamase, Hideki Horibe, Chikara Ueyama, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Masazumi Arai, Sachiro Watanabe, Yoshiji Yamada.
    Association of polymorphisms of TOMM40 and SLC22A4 with ischemic stroke.
    Biomed Rep 2015;3:491-498.

  38. Yoshiji Yamada, Kota Matsui, Ichiro Takeuchi, Tetsuo Fujimaki.
    Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study.
    Int J Mol Med 2015;35:1290-1300.

  39. Yoshiji Yamada, Kota Matsui, Ichiro Takeuchi, Tetsuo Fujimaki.
    Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study.
    Biomed Rep 2015;3:413-419.

  40. Yoshiji Yamada, Kota Matsui, Ichiro Takeuchi, Mitsutoshi Oguri, Tetsuo Fujimaki.
    Association of genetic variants of the alpha-kinase 1 gene with type 2 diabetes mellitus in a longitudinal population-based genetic epidemiological study.
    Biomed Rep 2015;3:347-354.

  41. Yoshiji Yamada, Kota Matsui, Ichiro Takeuchi, Mitsutoshi Oguri, Tetsuo Fujimaki.
    Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study.
    Int J Mol Med 2015;35:1189-1198.

  42. Hideki Horibe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Reiko Matsuoka, Shintaro Abe, Fumitaka Tokoro, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Yoshiji Yamada.
    Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals.
    Nephrology 2015;20:273-278.

  43. Shintaro Abe, Fumitaka Tokoro, Reiko Matsuoka, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Hideki Horibe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Shinya Minatoguchi, Yoshiji Yamada.
    Association of genetic variants with dyslipidemia.
    Mol Med Rep 2015;12:5429-5436.

  44. Reiko Matsuoka, Shintaro Abe, Fumitaka Tokoro, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Hideki Horibe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Shinya Minatoguchi, Yoshiji Yamada.
    Association of six genetic variants with myocardial infarction.
    Int J Mol Med 2015;35:1451-1459.

  45. Fumitaka Tokoro, Reiko Matsuoka, Shintaro Abe, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Hideki Horibe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Shinya Minatoguchi, Yoshiji Yamada.
    Association of a genetic variant of the ZPR1 zinc finger gene with type 2 diabetes mellitus.
    Biomed Rep 2015;3:88-92.

  46. Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Kimihiko Kato, Reiko Matsuoka, Shintaro Abe, Fumitaka Tokoro, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Yoshiji Yamada.
    Association of a transcription factor 21 gene polymorphism with hypertension.
    Biomed Rep 2015;3:118-122.

  47. Miki Yamada, Noriko Sato, Shinobu Ikeda, Tomio Arai, Motoji Sawabe, Seijiro Mori, Yoshiji Yamada, Masaaki Muramatsu, Masashi Tanaka.
    Association of the chromodomain helicase DNA-binding protein 4 (CHD4) missense variation p.D140E with cancer: potential interaction with smoking.
    Genes Chromosomes Cancer 2015;54:122-128.

  48. Huang Z, Ichihara S, Oikawa S, Chang J, Zhang L, Hu S, Huang H, Ichihara G.
    Hippocampal phosphoproteomics of F344 rats exposed to 1-bromopropane.
    Toxicol Appl Pharmacol 2015;282:151-160.

  49. Tada-Oikawa S, Ichihara G, Suzuki Y, Izuoka K, Yamada Y, Mishima T, Ichihara S.
    Zn(II) released from zinc oxide nano/micro particles was involved in the attenuation of vasculogenesis in human endothelial colony-forming cells.
    Toxicol Rep 2015;2:692-701.

  50. Chang J, Ichihara G, Shimada S, Tada-Oikawa S, Suzuki Y, Radwa S, Kato M, Tanaka T,Ichihara S.
    Copper oxide nanoparticles reduce vasculogenesis in transgenic zebrafish through down-regulation of vascular endothelial growth factor expression and induction of apoptosis.
    J Nanosci Nanotechnol 2015;15:2140-2417.

  51. Heying Zhou, Seijiro Mori, Masashi Tanaka, Motoji Sawabe, Tomio Arai, Masaaki Muramatsu, Makiko Naka-Mieno, Shoji Shinkai, Yoshiji Yamada, Motohiko Miyachi, Haruka Murakami, Kiyoshi Sanada, Hideki Ito.
    A missense single nucleotide polymorphism, V114I of the Werner syndrome gene, is associated with the risk of osteoporosis and femoral fracture in the Japanese population.
    J Bone Miner Metab 2015;33:694-700.

  52. Lau, Q., Yasukochi, Y., Satta, Y.
    A limit to the divergent allele advantage model supported by variable pathogen recognition across HLA-DRB1 allele lineages.
    Tissue Antigens 2015;86:343-352.

  53. Yasukochi, Y., Naka, I., Hananantachai, H., Patarapotikul, J., Ohashi, J.
    Genetic evidence for contribution of human dispersal to the genetic diversity of EBA-175 in Plasmodium falciparum.
    Malar J 2015;14:293.

  54. Yasukochi, Y., Satta, Y.
    Molecular evolution of the CYP2D subfamily in primates: Purifying selection on substrate recognition sites without the frequent or long-tract gene conversion.
    Genome Biology and Evolution 2015;7:1053-1067.

  55. -2014-
  56. Wu W, Ichihara G, Hashimoto N, Hasegawa Y, Hayashi Y, Tada-Oikawa S, Suzuki Y, Chang J, Kato M, D'Alessandro-Gabazza CN, Gabazza ES, Ichihara S.
    Snergistic effect of bolus exposure to zinc oxide nanoparticles on bleomycin-induced secretion of pro-fibrotic cytokines without lasting fibrotic changes in murine lungs.
    Int J Mol Sci 2014;16:660-676.

  57. Ziad A Ali, Vinicio de Jesus Perez, Ke Yuan, Mark Orcholski, Stephen Pan, Wei Qi, Gaurav Chopra, Christopher Adams, Yoko Kojima, Nicholas J Leeper, Xiumei Qu, Kathia Zaleta-Rivera, Kimihiko Kato, Yoshiji Yamada, Mitsutoshi Oguri, Allan Kuchinsky, Stanley L Hazen, J Wouter Jukema, Santhi K Ganesh, Elizabeth G Nabel, Keith Channon, Martin B Leon, Alain Charest, Thomas Quertermous, Euan A Ashley.
    Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1.
    J Clin Invest 2014;124:159-174.

  58. Yoshiko Murakata, Tetsuo Fujimaki, Yoshiji Yamada.
    Association of a butyrophilin, subfamily 2, member A1 gene polymorphism with hypertension.
    Biomed Rep 2014;2:818-822.

  59. Yoshiji Yamada, Tamotsu Nishida, Hideki Horibe, Mitsutoshi Oguri, Kimihiko Kato, Motoji Sawabe.
    Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.
    Int J Mol Med 2014;33:1355-1363.

  60. Hideki Horibe, Chikara Ueyama, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Sahoko Ichihara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with dislipidemia in community-dwelling individuals.
    Mol Med Rep 2014;9:808-812.

  61. Jie Chang, Shinji Oikawa, Hitoshi Iwahashi, Emiko Kitagawa, Ichiro Takeuchi, Masao Yuda, Chieko Kato, Yoshiji Yamada, Gaku Ichihara, Masashi Kato, Sahoko Ichihara.
    Expression of proteins associated with adipocyte lipolysis was significantly changed in the adipose tissues of the obese spontaneously hypertensive/NDmcr-cp rat.
    Diabetol Metab Syndr 2014;6:8.

  62. Tiago V. Pereira, Lilian Kimura, Yasushi Suwazono, Hideaki Nakagawa, Makoto Daimon, Toshihide Oizumi, Takamasa Kayama, Takeo Kato, Liao Li, Shufeng Chen, Dongfeng Gu, Wilfried Renner, Winfried Marz, Yoshiji Yamada, Pantelis G. Bagos, Regina C.
    Mingroni-Netto. Multivariate meta-analysis of the association of G-protein beta 3 gene (GNB3) haplotypes with cardiovascular phenotypes.
    Mol Biol Rep 2014;41:3113-3125.

  63. Tetsuo Fujimaki, Hideki Horibe, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada.
    Association of genetic variants of the α-kinase 1 gene with myocardial infarction in community-dwelling individuals.
    Biomed Rep 2014;2:127-31.

  64. Suzuki Y, Mitsushima S, Kato A, Yamaguchi T, Ichihara S.
    High-phosphorus/zinc-free diet aggravates hypertension and cardiac dysfunction in a rat model of the metabolic syndrome.
    Cardiovasc Pathol 2014;23:43-49.

  65. Wu Y, Gao H, Li H, Tabara Y, Nakatochi M, Chiu YF, Park EJ, Wen W, Adair LS, Borja JB, Cai Q, Chang YC, Chen P, Croteau-Chonka DC, Fogarty MP, Gan W, He CT, Hsiung CA, Hwu CM, Ichihara S, Igase M, Jo J, Kato N, Kawamoto R, Kuzawa CW, Lee JJ, Liu J, Lu L, McDade TW, Osawa H, Sheu WH, Teo Y, Vadlamudi S, Van Dam RM, Wang Y, Xiang YB, Yamamoto K, Ye X, Young TL, Zheng W, Zhu J, Shu XO, Shin C, Jee SH, Chuang LM, Miki T, Yokota M, Lin X, Mohlke KL, Tai ES.
    A meta-analysis of genome-wide association studies for adiponectin level in East Asians identifies a novel locus near WDR11-FGFR2.
    Hum Mol Genet 2014;23:1108-1119.

  66. Wu W, Ichihara G, Suzuki Y, Izuoka K, Tada-Oikawa S, Chang J, Sakai K, Miyazawa K, Porter D, Castranova V, Kawaguchi M, Ichihara S.
    Dispersion method for safety research on manufactured nanomaterials.
    Ind Health 2014;52:54-65.

  67. Iida M, Yajima I, Ohgami N, Tamura H, Takeda K, Ichihara S, Hori M, Kato M.
    The effects of non-thermal atmospheric pressure plasma irradiation on expression levels of matrix metalloproteinases in benign melanocytic tumors in RET-transgenic mice.
    Eur J Dermatol 2014;24:392-394.

  68. Suzuki Y, Tada-Oikawa S, Ichihara G, Yabata T, Izuoka K, Suzuki M, Sakai K, Ichihara S.
    Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation.
    Toxicol Appl Pharmacol 2014;278:16-25.

  69. Yajima I, Iida M, Kumasaka M, Omata Y, Ohgami N, Chang J, Ichihara S, Hori M, Kato M.
    Non-equilibrium atmospheric pressure plasmas modulate cell cycle-related gene expression levels in melanocytic tumors of RET-transgenic mice.
    Exp Dermatol 2014;23:424-425.

  70. Yasukochi, Y., Satta, Y.
    A human-specific allelic group of the MHC DRB1 gene in primates.
    J Physiol Anthropol 2014;33:14.

  71. Yasukochi, Y, Satta, Y.
    Nonsynonymous substitution rate heterogeneity in the peptide-binding region among different HLA-DRB1 lineages in humans.
    G3 (Bethesda) 2014;4:1217-1226.

  72. -2013-
  73. Ichihara S, Yamamoto K, Asano H, Nakatochi M, Sukegawa M, Ichihara G, Izawa H, Hirashiki A, Takatsu F, Umeda H, Iwase M, Inagaki H, Hirayama H, Sone T, Nishigaki K, Minatoguchi S, Cho M-C, Jang Y, Kim H-S, Park JE, Tada-Oikawa S, Kitajima H, Matsubara T, Sunagawa K, Shimokawa H, Kimura A, Lee J-Y, Inoue I, Yokota M.
    A genome-wide linkage study identifies glutamic acid repeat polymorphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction.
    Circ Cardiovasc Genet 2013;6:569-578.

  74. Mohideen SS, Ichihara S, Subramanian K, Hunag Z, Naitoh H, Kitoh J, Ichihara G.
    Effects of Exposure to 1-Bromopropane on Astrocytes and Oligodendrocytes in Rat Brain.
    J Occup Health 2013;55:29-38.

  75. Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Sahoko Ichihara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with chronic kidney disease in community-dwelling individuals.
    Biomed Rep 2013;1:868-872.

  76. Shigetaka Shimokata, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Yoshiji Yamada.
    Association between polymorphisms of the α-kinase 1 gene and type 2 diabetes mellitus in community-dwelling individuals.
    Biomed Rep 2013;1:940-944.

  77. Chikara Ueyama, Hideki Horibe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada.
    Association of genetic variants of CELSR1 and 3q28 with hypertension in community-dwelling individuals.
    Biomed Rep 2013;1:840-844.

  78. Yuka Suzuki, Gaku Ichihara, Sheik Mohideen Sahabudeen, Ai Kato, Takanori Yamaguchi, Kyoko Imanaka-Yoshida, Toshimichi Yoshida, Yoshiji Yamada, Sahoko Ichihara.
    Rats with metabolic syndrome resist the protective effects of N-acetyll-cystein against impaired spermatogenesis induced by high-phosphorus/zinc-free diet.
    Exp Toxicol Pathol 2013;65:1173-1182.

  79. Takanori Yamaguchi, Kazuya Kitamori, Gaku Ichihara, Yuka Suzuki, Miyuki Ochiai, Yoshiji Yamada, Saeko Tada-Oikawa, Satoru Tsuchikura, Yukio Yamori, Sahoko Ichihara.
    Serial changes in adipocytokines and cardiac function in a rat model of the metabolic syndrome.
    Clin Exp Pharmacol Physiol 2013;40:443-448.

  80. Yoshiji Yamada, Tamotsu Nishida, Sahoko Ichihara, Kimihiko Kato, Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Michio Fukuda, Motoji Sawabe.
    Identification of 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study.
    J Med Genet 2013;50:410-418.

  81. Yasukochi, Y., Satta, Y.
    Current perspectives on the intensity of natural selection of MHC loci.
    Immunogenetics 65:479-483.

  82. -2012-
  83. Jie Chang, Shinji Oikawa, Gaku Ichihara, Yui Nanpei, Yasuhiro Hotta, Yoshiji Yamada, Saeko Tada-Oikawa, Hitoshi Iwahashi, Emiko Kitagawa, Ichiro Takeuchi, Masao Yuda, Sahoko Ichihara.
    Altered gene and protein expression in liver of the obese spontaneously hypertensive/NDmcr-cp rat.
    Nutr Metab 2012;9:87.

  84. Mizuho Hiramatsu, Mitsutoshi Oguri, Kimihiko Kato, Hideki Horibe, Tetsuo Fujimaki, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Dong-Jik Shin, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome in East Asian populations.
    Int J Mol Med 2012;30:185-192.

  85. Robert Clarke, Derrick Bennett, Sarah Parish, Petra Verhoef, Mariska Dotsch-Klerk, Mark Lathrop, Peng Xu, Borge G Nordestgaard, Hilma Holm, Jemma C Hopewell, Danish Saleheen, Toshihiro Tanaka, Sonia S Anand, John Chambers, Marcus E Kleber, Willem H Ouwehand, Yoshiji Yamada, Clara Elbers, Bas Peters, Alexandre Stewart, Muredach M Reilly, Barbara Thorand, Salim Yusuf, James C Engert, Themistocles L Assimes, Jaspal Kooner, John Danesh, Hugh Watkins, Nilesh J Samani, Rory Collins, Richard Peto for the MTHFR Studies Collaborative Group.
    Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
    PLoS Med 2012;9:e1001177.

  86. Kimihiko Kato, Yoshiyuki Tokuda, Naohiko Inagaki, Tetsuro Yoshida, Tetsuo Fujimaki, Mitsutoshi Oguri, Takeshi Hibino, Kiyoshi Yokoi, Toyoaki Murohara, Yoshiji Yamada.
    Association of a matrix metallopeptidase gene (MMP1) polymorphism with long-term outcome of thoracic aortic aneurysm.
    Int J Mol Med 2012;29:125-132.

  87. -2011-
  88. Mitsutoshi Oguri, Kimihiko Kato, Tetsuro Yoshida, Tetsuo Fujimaki, Hideki Horibe, Kiyoshi Yokoi, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Dong-jik Shin, Jon Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations.
    J Med Genet 2011;48:787-792.

  89. Tanimura D, Shibata R, Izawa H, Hirashiki A, Asano H, Murase Y, Miyata S, Nakatochi M, Ouchi N, Ichihara S, Yasui K, Yoshida T, Naruse K, Matsubara T, Yokota M.
    Relation of a common variant of the adiponectin gene to serum adiponectin concentration and metabolic traits in an aged Japanese population.
    Eur J Hum Genet 2011;19:262-269.

  90. Reiko Ban, Tamotsu Nishida, Takeshi Urano.
    Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
    Genes Cells 2011;16:652-669.

  91. Tetsuo Fujimaki, Kimihiko Kato, Mitsutoshi Oguri, Tetsuro Yohida, Hideki Horibe, Kiyoshi Yokoi, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Dong-Jik Shin, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations.
    Exp Ther Med 2011;2:745-749.

  92. Tetsuro Yoshida, Kimihiko Kato, Hideki Horibe, Mitsutoshi Oguri, Michio Fukuda, Kei Satoh, Yukitoshi Aoyagi, Shoji Shinkai, Yoshinori Nozawa, Yoshiji Yamada.
    Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals.
    Nephrology 2011;16:642-648.

  93. Mizuho Hiramatsu, Mitsutoshi Oguri, Kimihiko Kato, Tetsuro Yoshida, Tetsuo Fujimaki, Hideki Horibe, Kiyoshi Yokoi, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus in Japanese individuals.
    Diabetic Med 2011;28:1381-1387.

  94. Hideki Horibe, Kimihiko Kato, Mitsutoshi Oguri, Tetsuro Yoshida, Tetsuo Fujimaki, Toshiki Kawamiya, Kiyoshi Yokoi, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with hypertension in Japanese individuals.
    Am J Hypertens 2011;24:924-929.

  95. Tamotsu Nishida, Yoshiji Yamada.
    The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Biochem Biophys Res Commun 2011;406:285-291.

  96. Tetsuro Yoshida, Kimihiko Kato, Mitsutoshi Oguri, Hideki Horibe, Toshiki Kawamiya, Kiyoshi Yokoi, Tetsuo Fujimaki, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Yoshiji Yamada.
    Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus, or chronic kidney disease.
    Int J Mol Med 2011;27:745-752.

  97. Tetsuro Yoshida, Kimihiko Kato, Mitsutoshi Oguri, Hideki Horibe, Toshiki Kawamiya, Kiyoshi Yokoi, Tetsuo Fujimaki, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Yoshiji Yamada.
    Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with different lipid profiles.
    Mol Med Rep 2011;4:511-518.

  98. Tetsuro Yoshida, Kimihiko Kato, Mitsutoshi Oguri, Hideki Horibe, Toshiki Kawamiya, Kiyoshi Yokoi, Tetsuo Fujimaki, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Hiroto Yoshida, Shoji Shinkai, Yoshinori Nozawa, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus.
    Exp Ther Med 2011;2:325-331.

  99. Yoshiji Yamada, Tamotsu Nishida, Sahoko Ichihara, Motoji Sawabe, Noriyuki Fuku, Yutaka Nishigaki, Yukitoshi Aoyagi, Masashi Tanaka, Yoshinori Fujiwara, Hiroto Yoshida, Shoji Shinkai, Kei Satoh, Kimihiko Kato, Tetsuo Fujimaki, Kiyoshi Yokoi, Mitsutoshi Oguri, Tetsuro Yoshida, Sachiro Watanabe, Yoshinori Nozawa, Aki Hasegawa, Toshio Kojima, Bok-Ghee Han, Younjin Ahn, Meehee Lee, Dong-Jik Shin, Jong Ho Lee, Yangsoo Jang.
    Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.
    Atherosclerosis 2011;215:145-152.

  100. Tiago V. Pereira, Regina C. Mingroni-Netto, Yoshiji Yamada.
    ADRB2 and LEPR gene polymorphisms: synergistic effects on the risk of obesity in Japanese.
    Obesity 2011;19:1523-1527.

  101. Tanimura D, Shibata R, Izawa H, Hirashiki A, Asano H, Murase Y, Miyata S, Nakatochi M, Ouchi N, Ichihara S, Yasui K, Yoshida T, Naruse K, Matsubara T, Yokota M.
    Relation of a common variant of the adiponectin gene to serum adiponectin concentration and metabolic traits in an aged Japanese population.
    European Journal of Human Genetics 2011;19:262-269.

  102. Nakatochi M, Miyata S, Tanimura D, Izawa H, Asano H, Murase Y, Kato R, Ichihara S, Naruse K, Matsubara T, Honda H, Yokota M.
    The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: Results from the KING Study.
    Diabetes Research and Clinical Practice 2011;92:e61-65.

  103. Mohideen SS, Ichihara S, Nakamura S, Ichihara G.
    Exposure to 1-bromopropane causes degeneration of noradrenergic axons in the rat brain.
    Toxicology 2011;285:67-71.

  104. Elshazley M, Shibata E, Hisanaga N, Ichihara G, Ewis AA, Kamijima M, Ichihara S, Sakai K, Sato M, Kondo M, Hasegawa Y.
    Pleural plaques profile on chest radiograph and CT scan of asbestos-exposed Japanese construction workers.
    Industrial Health 2011;49:626-633.

  105. Ichihara G, Wang H, Zhang L, Wakai K, Li W, Ding X, Shibata E, Zhou Z, Wang Q, Li J, Ichihara S, Takeuchi Y.
    Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane: authors' response.
    Journal of Occupational and Environmental Medicine 2011;53:1095-1098.

  106. Huang Z, Ichihara S, Oikawa S, Chang J, Zhang L, Takahashi M, Subramanian K, Mohideen SS, Wang Y, Ichihara G.
    Proteomic analysis of hippocampal proteins of F344 rats exposed to 1-bromopropane.
    Toxicology and Applied Pharmacology 2011;257:93-101.

  107. Ichihara G, Kitoh J, Li W, Ding X, Ichihara S, Takeuchi Y.
    Neurotoxicity of 1-bromopropane: Evidence from animal experiments and human studies.
    Journal of Advanced Research 2011 (in press)

  108. -2010-
  109. Fang Liu, Sahoko Ichihara, William M Valentine, Ken Ito, Masayuki Yamamoto, Sahabdeen S Mohideen, Uka Sai, Junzoh Kito, Gaku Ichihara.
    Increased susceptibility of Nrf2-null mice to 1-bromopropane-induced hepatotoxicity.
    Toxicol Sci 2010;115:596-606.

  110. Weihua Li, Eiji Shibata, Zhijun Zhou, Sahoko Ichihara, Hailan Wang, Qiangyi Wang, Jefe Lie, Lingy Zhang, Kenji Wakai, Yasuhiro Takeuchi, Xuncheng Ding, Gaku Ichihara.
    Dose-Dependent Neurologic Abnormalities in Workers Exposed to 1-Bromopropane.
    J Occup Environ Med 2010;52:769-777.

  111. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration.
    Triglyceride-mediated pathways and coronary disease: collaborative analysis for 101 studies.
    Lancet 2010;375:1634-1639.

  112. Toshiki Kawamiya, Kimihiko Kato, Hideki Horibe, Kiyoshi Yokoi, Mitsutoshi Oguri, Tetsuro Yoshida, Tetsuo Fujimaki, Sachiro Watanabe, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with or without metabolic syndrome.
    Exp Ther Med 2010;1:969-975.

  113. Sahoko Ichihara, Yoshiji Yamada, Fang Liu, Toyoaki Murohara, Ken Itoh, Masayuki Yamamoto, Gaku Ichihara.
    Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response.
    Arterioscler Thromb Vasc Biol 2010;30:1553-1561.

  114. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with hemorrhagic stroke in Japanese individuals.
    Int J Mol Med 2010;25:649-656.

  115. Tetsuo Fujimaki, Kimihiko Kato, Kiyoshi Yokoi, Tetsuro Yoshida, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Genetic risk for myocardial infarction in Japanese individuals with or without chronic kidney disease.
    Int J Mol Med 2010;25:743-749.

  116. Mitsutoshi Oguri, Takanori Nagahiro, Haruo Kamiya, Miyoshi Ohno, Kimihiko Kato, Kiyoshi Yokoi, Tetsuro Yoshida, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of a polymorphism of ROR2 and ischemic stroke in Japanese individuals with chronic kidney disease.
    Exp Ther Med 2010;1:377-384.

  117. Tetsuo Fujimaki, Kimihiko Kato, Kiyoshi Yokoi, Tetsuro Yoshida, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Genjiro Kimura, Yoshiji Yamada.
    Association of genetic variants in SEMA3F, CLEC16A, LAMA3, and PCSK2 with myocardial infarction in Japanese individuals.
    Atherosclerosis 2010;210:468-473.

  118. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with ischemic stroke in Japanese individuals with or without metabolic syndrome.
    Int J Mol Med 2010;25:281-286.

  119. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with different lipif profiles.
    Int J Mol Med 2010;25:607-616.

  120. Mitsutoshi Oguri, Kimihiko Kato, Kiyoshi Yokoi, Tetsuro Yoshida, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Assessment of a polymorphism of SDK1 with hypertension in Japanese individuals.
    Am J Hypertens 2010;23:70-77.

  121. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus.
    Exp Ther Med 2010;1:137-145.

  122. Yosuke Kato, Mitsunori Iwase, Sahoko Ichihara, Hiroaki Kanazawa, Katsunori Hashimoto, Akiko Noda, Kohzo Nagata, Yasuo Koike, Mitsuhiro Yokota.
    Beneficial effects of growth hormone-releasing Peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Circ J 2010;74:163-170.

  123. -2009-
  124. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in individuals with or without hypertension or diabetes mellitus.
    Int J Mol Med 2009;24:701-709.

  125. Sheik Mohideen Sahabudeen, Sahoko Ichihara, Shameema Banu, Fang Liu, Junzo Kitoh, Gaku Ichihara.
    Changes in neurotransmitter receptor expression levels in rat brain after 4-week exposure to 1-bromopropane.
    Neurotoxicology 2009;30:1078-1083.

  126. Fang Liu, Sahoko Ichihara, Sheik Mohideen Sahabudeen, Uka Sai, Junzo Kitoh, Gaku Ichihara.
    Comparative study on susceptibility to 1-bromopropane in three mice strains.
    Toxicol Sci 2009;112:100-110.

  127. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Yoshiji Yamada.
    Association of gene polymorphisms with chronic kidney disease in Japanese individuals.
    Int J Mol Med 2009;24:539-547.

  128. Kunihiko Hinohara, Toshiaki Nakajima, MichioYasunami, Shigeru Houda, Taishi Sasaoka, Ken Yamamoto, Bok-Soo Lee, Hiroki Shibata, Yumiko Tanaka-Takahashi, Megumi Takahashi, Takuro Arimura, Akinori Sato, Taeko Naruse, Jimin Ban, Hidetoshi Inoko, Yoshiji Yamada, Motoji Sawabe, Jeong-Euy Park, Toru Izumi, Akinori Kimura.
    Megakaryoblastic leukemia factor-1 gene in the susceptibility to coronary artery disease.
    Hum Genet 2009;126:539-547.

  129. Yoshiji Yamada, Noriyuki Fuku, Masashi Tanaka, Yukitoshi Aoyagi, Motoji Sawabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Kimihiko Kato, Sachiro Watanabe, Yoshinori Nozawa, Aki Hasegawa, Toshio Kojima.
    Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study.
    Atherosclerosis 2009;207:144-149.

  130. Mitsutoshi Oguri, Kimihiko Kato, Kiyoshi Yokoi, Tetsuro Yoshida, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Masashi Tanaka, Yoshinori Nozawa, Yoshiji Yamada.
    Association of a polymorphism of BCHE with ischemic stroke in Japanese individuals with chronic kidney disease.
    Mol Med Rep 2009;2:779-785.

  131. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with chronic kidney disease in individuals with different lipid profiles.
    Int J Mol Med 2009;24:233-246.

  132. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Yoshinori Nozawa, Yoshiji Yamada.
    Association of gene polymorphisms with chronic kidney disease in high-risk or low-risk subjects defined by conventional risk factors.
    Int J Mol Med 2009;23:785-792.

  133. Mitsutoshi Oguri, Kimihiko Kato, Kiyoshi Yokoi, Tatsuo Itoh, Tetsuro Yoshida, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Masashi Tanaka, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome.
    Atherosclerosis 2009;206:486-493.

  134. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Sachiro Watanabe, Norifumi Metoki, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Yoshinori Nozawa, Yoshiji Yamada.
    Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension.
    Hypertens Res 2009;32:411-418.

  135. Tetsuro Yoshida, Kimihiko Kato, Tetsuo Fujimaki, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Masashi Tanaka, Yoshinori Nozawa, Genjiro Kimura, Yoshiji Yamada.
    Association of genetic variants with chronic kidney disease in Japanese individuals.
    Clin J Am Soc Nephrol 2009;4:883-890.

  136. Hiroyuki Uekusa, Mihoko Namimatsu, Yusuke Hiwatashi, Takuya Akimoto, Tamotsu Nishida, Shigeru Takahashi, Yuji Takahashi.
    Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway.
    Biochem Biophys Res Commun 2009;380:673-678.

  137. Sahoko Ichihara, Yoshiji Yamada, Frank J. Gonzalez, Tamie Nakajima, Toyoaki Murohara, Gaku Ichihara.
    Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner dependent on the aryl hydrocarbon receptor.
    Biochem Biophys Res Commun 2009;381:44-49.

  138. Tetsuo Fujimaki, Kimihiko Kato, Tetsuro Yoshida, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Masashi Tanaka, Yoshinori Nozawa, Genjiro Kimura, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with chronic kidney disease.
    Thromb Haemost 2009;101:963-968.

  139. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of polymorphisms of SORBS1, GCK, and WISP1 with hypertension in community-dwelling Japanese individuals.
    Hypertens Res 2009;32:325-331.

  140. Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Takao Suzuki, Yoshinori Nozawa, Yoshiji Yamada.
    Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus.
    Int J Mol Med 2009;23:529-537.

  141. Satoko Minami, Kousei Ito, Masashi Honma, Yuki Ikebuchi, Naohiko Anzai, Yoshikatsu Kanai, Tamotsu Nishida, Sachiko Tsukita, Shuichi Sekine, Toshiharu Horie, Hiroshi Suzuki.
    Post-translational regulation of Abcc2 expression by SUMOylation system.
    Am J Physiol Gastrointest Liver Physiol 2009;296:G406-413.

  142. Tetsuro Yoshida, Kimihiko Kato, Tetsuo Fujimaki, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Masashi Tanaka, Yoshinori Nozawa, Yoshiji Yamada.
    Association of a polymorphism of apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome.
    Genomics 2009;93:221-226.

  143. Mitsutoshi Oguri, Kimihiko Kato, Kiyoshi Yokoi, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Hideyo Yoshida, Yoshinori Nozawa, Yoshiji Yamada.
    Association of polymorphisms of THBS2 and HSPA8 with hypertension in Japanese individuals with chronic kidney disease.
    Mol Med Rep 2009;2:205-211.

  144. -2008-
  145. Ayako Muraoka, Atsuyo Maeda, Norie Nakahara, Midori Yokota, Tamotsu Nishida, Tokumi Maruyama, Takayuki Ohshima.
    Sumoylation of CoREST modulates its function as a transcriptional repressor.
    Biochem Biophys Res Commun 2008;377:1031-1035.

  146. Tamotsu Nishida, Yoshiji Yamada.
    SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Biochem Biophys Res Commun 2008;374:382-387.

  147. Kimihiko Kato, Mitsutoshi Oguri, Noriyuki Kato, Takeshi Hibino, Kazuhiro Yajima, Tetsuo Yoshida, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sachiro Watanabe, Kiyoshi Yokoi, Toyoaki Murohara, Yoshiji Yamada.
    Assessment of genetic risk factors for thoracic aortic aneurysm in hypertensive patients.
    Am J Hypertens 2008;21:1023-1027.

  148. Yoshiji Yamada, Kimihiko Kato, Mitsutoshi Oguri, Tetsuro Yoshida, Kiyoshi Yokoi, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa.
    Association of candidate gene polymorphisms with atherothrombotic cerebral infarction among Japanese indivuduals with metabolic syndrome.
    Int J Mol Med 2008;21:801-808.

  149. Sahoko Ichihara, Yoshiji Yamada, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Hitoshi Matsuo, Tai Kojima, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa.
    Association of a polymorphism of ABCB1 with obesity in Japanese individuals.
    Genomics 2008;91:512-516.

  150. Masaharu Takemura, Kazuto Sugimura, Katsuzumi Okumura, Siripan Limsirichaikul, Motoshi Suzuki, Yoshiji Yamada, Shonen Yoshida.
    Hyper-phosphorylated retinoblastoma protein suppresses telomere elongation.
    Biosci Biotech Biochem 2008;72:70715-1-6.

  151. Yoshiji Yamada, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sachiro Watanabe, Sahoko Ichihara, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa.
    Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals.
    Stroke 2008;39:2211-2218.

  152. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of genetic variants of APOA5 and PRKCH with hypertension in community-dwelling Japanese individuals.
    Mol Med Rep 2008;1:407-414.

  153. Tiago Veiga Pereira, Ane Claudia F. Nunes, Martina Rudnicki, Yoshiji Yamada, Alexandre Costa Pereira, Jose Eduardo Krieger.
    Meta-analysis of the association of four angiotensinogen polymorphisms with essential hypertension: a role beyond M235T?
    Hypertension 2008;51:778-783.

  154. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of genetic variants of MAOA and SH2B1 with bone mineral density in community-dwelling Japanese women.
    Mol Med Rep 2008;1:269-274.

  155. Yoshiji Yamada, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Kiyoshi Yokoi, Hitoshi Matsuo, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa.
    Genetic risk for myocardial infarction determined by polymorphisms of candidate genes in Japanese population.
    J Med Genet 2008;45:216-21.

  156. Yoshiji Yamada, Kimihiko Kato, Tetsuro Yoshida, Kiyoshi Yokoi, Hitoshi Matsuo, Sachiro Watanabe, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa.
    Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals.
    Int J Mol Med 2008;21:83-89.

  157. Yoshiji Yamada, Kimihiko Kato, Tetsuro Yoshida, Kiyoshi Yokoi, Hitoshi Matsuo, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Wan Lee, Yoshinori Nozawa.
    Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese individuals.
    J Med Genet 2008;45:22-28.

  158. -2007-
  159. Yoshiji Yamada, Hitoshi Matsuo, Sachiro Watanabe, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus.
    Int J Mol Med 2007;20:703-707.

  160. Yoshiji Yamada, Hitoshi Matsuo, Shunichiro Warita, Sachiro Watanabe, Kimihiko Kato, Mitsutoshi Oguri, Kiyoshi Yokoi, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa.
    Prediction of genetic risk for dyslipidemia.
    Genomics 2007;90:551-558.

  161. Mitsutoshi Oguri, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Tomonori Segawa, Hitoshi Matsuo, Sachiro Watanabe, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Identification of a polymorphism of UCP3 associated with recurrent in-stent restenosis of coronary arteries.
    Int J Mol Med 2007;20:533-538.

  162. Tamotsu Nishida, Motoko Terashima, Kiyoko Fukami, Yoshiji Yamada.
    Repression of E1AF transcription activity by sumoylation and PIASy.
    Biochem Biophys Res Commun 2007;360:226-232.

  163. Tetsuro Yoshida, Kazuhiro Yajima, Takeshi Hibino, Kimihiko Kato, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Mitsutoshi Oguri, Kiyoshi Yokoi, Yoshinori Nozawa, Genjiro Kimura, Yoshiji Yamada.
    Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.
    Int J Mol Med 2007;20:581-590.

  164. Tiago V. Pereira, Martina Rudnicki, Bernard M. Y. Cheung, Larry Baum, Yoshiji Yamada, Paulo S. L. Oliveira, Alexandre C. Pereira, Jose E. Krieger.
    Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensives and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias.
    J Hypertens 2007;25:1763-1774.

  165. Sahoko Ichihara, Yoshiji Yamada, Yoshichika Kawai, Toshihiko Osawa, Koichi Furuhashi, Zhi-wen Duan, Gaku Ichihara.
    Roles of oxidative stress and Akt signaling in Doxorubicin cardiotoxicity.
    Biochem Biophys Res Commun 2007;359:27-33.

  166. Tamotsu Nishada, Motoko Terashima, Kiyoko Fukami, Yoshiji Yamada.
    PIASy controls ubiquitination-dependent proteosomal degradation of Ets-1.
    Biochem J 2007;405:481-488.

  167. Sahoko Ichihara, Yoshiji Yamada, Gaku Ichihara, Li Ping, Takahisa Kondo, Frank J. Gonzales, Toyoaki Murohara.
    A role of aryl hydrocardon receptor in the regulation of angiogenesis.
    Arterioscler Thromb Vasc Biol 2007;27:1297-1304.

  168. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men.
    Int J Mol Med 2007;19:791-801.

  169. Sachiyo Yamaguchi, Yoshiji Yamada, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kiyoshi Yokoi, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus.
    Int J Mol Med 2007;19:631-637.

  170. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals.
    Int J Mol Med 2007;19:675-683.

  171. Kimihiko Kato, Mitsutoshi Oguri, Takeshi Hibino, Kazuhiro Yajima, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa, Kiyoshi Yokoi, Yoshiji Yamada.
    Genetic factors for lone atrial fibrillation.
    Int J Mol Med 2007;19:933-939.

  172. Mitsutoshi Oguri, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Tomonori Segawa, Hitoshi Matsuo, Sachiro Watanabe, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Genetic risk for restenosis after coronary stenting.
    Atherosclerosis 2007;194:e172-e178.

  173. Noriyuki Fuku, Kyong Soo Park, Yoshiji Yamada, Yutaka Nishigaki, Young Min Cho, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kiyoshi Yokoi, Yoshinori Nozawa, Hong Kyu Lee, Masashi Tanaka.
    Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians.
    Am J Hum Genet 2007;80:407-415.

  174. Masashi Tanaka, Noriyuki Fuku, Yutaka Nishigaki, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kiyoshi Yokoi, Masafumi Ito, Yoshinori Nozawa, Yoshiji Yamada.
    Women with mitochondrial haplogroup N9a are protected against metabolic syndrome.
    Diabetes 2007;56:518-521.

  175. Kohta Nishihama, Yoshiji Yamada, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kazuhiro Yajima, Takeshi Hibino, Kiyoshi Yokoi, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors.
    Int J Mol Med 2007;19:129-141.

  176. Yutaka Nishigaki, Yoshiji Yamada, Noriyuki Fuku, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kiyoshi Yokoi, Sachiyo Yamaguchi, Yoshinori Nozawa, Masashi Tanaka.
    Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males.
    Hum Genet 2007;120:827-836.

  177. Yutaka Nishigaki, Yoshiji Yamada, Noriyuki Fuku, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Kiyoshi Yokoi, Sachiyo Yamaguchi, Yoshinori Nozawa, Masashi Tanaka.
    Mitochondrial haplogroup A is a genetic risk factor for atherothrombotic cerebral infarction in Japanese females.
    Mitochondrion 2007;7:72-79.

  178. Yoshiji Yamada, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Sahoko Ichihara, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Prediction of genetic risk for metabolic syndrome.
    Atherosclerosis 2007;191:298-304.

  179. -2006-
  180. Sahoko Ichihara, Yoshiji Yamada, Gaku Ichihara, Hiroaki Kanazawa, Katsunori Hashimoto, Yousuke Kato, Aya Matsushita, Shinji Oikawa, Mitsuhiro Yokota, Mitsuniri Iwase.
    Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal mode of dilated cardiomyopathy.
    Biochem Biophys Res Commun 2006;350:105-113.

  181. Masako Saka, Koji Obata, Sahoko Ichihara, Xian Wu Cheng, Hirotaka Kimata, Akiko Noda, Hideo Izawa, Kohzo Nagata, Mitsuhiro Yokota.
    Attention of ventricular hypertrophy and fibrosis in rats by pitavastatin: Potential role RhoA-ERK-SRF pathway.
    Clin Exp Pharmacol Physiol 2006;33:1164-1171.

  182. Yoshiji Yamada, Kimihiko Kato, Takashi Kameyama, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Sahoko Ichihara, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Genetic factors for obesity.
    Int J Mol Med 2006;18:843-851.

  183. Sachiyo Yamaguchi, Yoshiji Yamada, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Kimihiko Kato, Takashi Kameyama, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Yoshinori Nozawa.
    Genetic risk for atherothrombotic cerebral infarction in individuals stratified by sex or conventional risk factors for athyerosclerosis.
    Int J Mol Med 2006;18:871-883.

  184. Yoshiji Yamada, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Assessment of genetic risk for myocardial infarction.
    Thromb Haemost 2006;96:220-227.

  185. Koichi Furuhashi, Junzoh Kitoh, Hiroko Tsukamura, Kei-ichiro Maeda, Hailan Wang, Weihua Li, Sahoko Ichihara, Tamie Nakajima, Gaku Ichihara.
    Effects of exposure of rat dams to 1-bromopropane during pregnancy and lactation on growth and sexual maturation of their offspring.
    Toxicology 2006;224:219-228.

  186. Masako Saka, Koji Obata, Sahoko Ichihara, Xian Wu Cheng, Hirotaka Kimata, Takao Nishizawa, Akiko Noda, Hideo Izawa, Kohzo Nagata, Toyoaki Murohara, Mitsuhiro Yokota.
    Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
    J Cardiovasc Pharmacol 2006;47:770-779.

  187. Masaharu Takemura, Shonen Yoshida, Tetsu Akiyama, Masatoshi Kitagawa, Yoshiji Yamada.
    Role of the second-largest subunit of DNA polymerase α in the interaction between the catalytic subunit and hyperphosphorylated retinoblastoma protein in late S phase.
    Biochim Biophys Acta - Proteins and Proteomics 2006;1764:1447-1453.

  188. Sahoko Ichihara, Koji Obata, Yoshiji Yamada, Kohzo Nagata, Akiko Noda, Gaku Ichihara, Akira Yamada, Tomoko Kato, Hideo Izawa, Toyoaki Murohara, Mitsuhiro Yokota.
    Attenuation of cardiac dysfunction by a PPAR-α agonist is associated with down-regulation of redox-regulated transcription factors.
    J Mol Cell Cardiol 2006;41:318-329.

  189. Yoshiji Yamada, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Takashi Kameyama, Kiyoshi Yokoi, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Assessment of the genetic factors for type 2 diabetes mellitus.
    Int J Mol Med 2006;18:299-308.

  190. Yoshiji Yamada, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Kimihiko Kato, Takashi Kameyama, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Yoshinori Nozawa.
    Genetic risk for ischemic and hemorrhagic stroke.
    Arterioscler Thromb Vasc Biol 2006;26:1920-1925.

  191. Yoshiji Yamada, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Hidemi Yoshida, Norifumi Metoki, Kei Satoh, Sahoko Ichihara, Yoshinori Nozawa.
    Assessment of genetic component for hypertension.
    Am J Hypertens 2006;19:1158-1165.

  192. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals.
    Int J Mol Med 2006;18:119-127.

  193. Kohzo Nagata, Koji Obata, Jinglan Xu, Sahoko Ichihara, Akiko Noda, Hirotaka Kimata, Hideo Izawa, Toyoaki Murohara, Mitsuhiro Yokota.
    Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Hypertension 2006;47:656-664.

  194. Yoshiyuki Mizushina, Rumi Nakanishia, Isoko Kuriyama, Kohei Kamiya, Toshiko Satake, Noriko Shimazaki, Osamu Koiwai, Yukinobu Uchiyama, Yuko Yonezawa, Masaharu Takemura, Kengo Sakaguchi and Hiromi Yoshida.
    β-Sitosterol-3-O-β-D-glucopyranoside: A eukaryotic DNA polymerase λ inhibitor.
    J Steroid Biochem Mol Biol 2006;99:100-107.

  195. Yoshiji Yamada, Yoshiko Banno, Hitoshi Yoshida, Ryosuke Kikuchi, Yukihiro Akao, Takashi Murate, Yoshinori Nozawa.
    Catalytic inactivation of human phospholipase D2 by a naturally occurring Gly901Asp mutation.
    Arch Med Res 2006;37:696-699.

  196. Sahoko Ichihara, Akiko Noda, Kohzo Nagata, Koji Obata, Jinglan Xu, Gaku Ichihara, Shinji Oikawa, Shosuke Kawanishi, Yoshiji Yamada, Mitsuhiro Yokota.
    Pravastatin increases survival and suppresses an increase in myocardial MMP activity in a rat model of heart failure.
    Cardiovasc Res 2006;69:726-735.

  197. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimikata.
    Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women.
    Int J Mol Med 2006;17:83-88.

  198. -2005-
  199. Koji Obata, Kohzo Nagata, Mitsuniri Iwase, Mari Odashima, Tstsuro Nagasaka, Yoshiji Yamada, Mitsuhiro Yokota.
    Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
    Biochem Biophys Res Commun 2005;338:1299-1305.

  200. Hideo Izawa, Toyoaki Murohara, Kohzo Nagata, Satoshi Isobe, Hiroyuki Asano,Tetsuya Amano, Sahoko Ichihara, Tomoko Kato, Satoru Ohshima, Yosuke Murase, Shigeo Iino, Koji Obata, Akiko Noda, Kenji Okumura, Mitsuhiro Yokota.
    Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Circulation 2005;112:2940-2945.

  201. Jinglan Xu, Kohzo Nagata, Koji Obata, Sahoko Ichihara, Hideo Izawa, Akiko Noda, Tetsuro Nagasaka, Mitsunori Iwase, Tomoki Naoe, Toyoaki Murohara, Mitsuhiro Yokota.
    Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats.
    Hypertension 2005;46:719-724.

  202. Isoko Kuriyama, Keiichi Musumi, Yuko Yonezawa, Masaharu Takemura, Naoki Maeda, Hiroshi Iijima, Takahiko Hada, Hiromi Yoshida and Yoshiyuki Mizushina.
    Inhibitory effects of glycolipids fraction from spinach on mammalian DNA polymerase activity and human cancer cell proliferation.
    J Nutr Biochem 2005;16:594-601.

  203. Masaharu Takemura.
    Evolutionary history of the retinoblastoma gene from archaea to eukarya.
    BioSystems 2005;82:266-272.

  204. Yoshiyuki Mizushina, Akiko Saito, Akira Tanaka, Noriyuki Nakajima, Isoko Kuriyama, Masaharu Takemura, Toshifumi Takeuchi, Fumio Sugawara, Hiromi Yoshida.
    Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors.
    Biochem Biophys Res Commun 2005;333:101-9.

  205. Yoshiji Yamada, Fujiko Ando, Hiroshi Shimokata.
    Association of polymorphisms in CYP17, MTP, and VLDLR with bone mineral density in community-dwelling Japanese women and men.
    Genomics 2005;86:76-85.

  206. Yoshiyuki Mizushina, K. Kuramochi, Hiroshi Ikawa, Isoko Kuriyama, N. Shimazaki, Masaharu Takemura, Masahiko Oshige, Hiromi Yoshida, Osamu Koiwai, Fumio Sugawara, S. Kobayashi, Kengo Sakaguchi.
    Structural analysis of epolactaene derivatives as DNA polymerase inhibitors and anti-inflammatory compounds.
    Int J Mol Med 2005;15:785-793.

  207. Isoko Kuriyama, Naoki Asano, Ikuo Kato, Kyoko Ikeda, Masaharu Takemura, Hiromi Yoshida, Kengo Sakaguchi, Yoshiyuki Mizushina.
    Dipeptide alcohol-based inhibitors of eukaryotic DNA polymerase α.
    Bioorg Medicin Chem 2005;13:2187-2196.

  208. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata.
    Association of a -1997G→T polymorphism of collagen Iα1 gene with bone mineral density.
    Hum Biol 2005;77:27-36.

  209. Yuko Yonezawa, Tsuyoshi Tsuzaki, Takahiro Eitsuka, Teruo Miyazawa, Takahiko Hada, Keisuke Uryu, Chikako Murakami-Nakai, Hiroshi Ikawa, Isoko Kuriyama, Masaharu Takemura, Masahiko Oshige, Hiromi Yoshida, Kengo Sakaguchi, Yoshiyuki Mizushina.
    Inhibitory effect of conjugated eicosapentaenoic acid on human DNA topoisomerases I and II.
    Arch Biochem Biophys 2005;435:197-206.

  210. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata.
    Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women.
    J Mol Med 2005;83:50-57.

  211. -2004-
  212. Takao Nishizawa, Mitsunori Iwase, Hiroaki Kanazawa, Sahoko Ichihara, Gaku Ichihara, Kohzo Nagata, Koji Obata, Kiyoyuki Kitaichi, Toyoharu Yokoi, Masato Watanabe, Takashi Tsunematsu, Yoshihiro Ishikawa, Toyoaki Murohara, Mitsuhiro Yokota.
    Serial Alterations of beta-Adrenergic Signaling in Dilated Cardiomyopathic Hamsters.
    Circ J 2004;68:1051-1060.

  213. Akira Yamada, Sahoko Ichihara, Yosuke Murase, Tomoko Kato, Hideo Izawa, Kohzo Nagata, Toyoaki Murohara, Yoshiji Yamada, Mitsuhiro Yokota.
    Lack of association of polymorphisms of the lymphotoxin α gene with myocardial infarction in Japanese.
    J Mol Med 2004;82:477-483.

  214. Masashi Tanaka, Vicente M. Cabrera, Ana M. Gonzalez, Jose M. Larruga, Takeshi Takeyasu, Noriyuki Fuku, Lin-Jun Guo, Raita Hirose, Yasunori Fujita, Miyuki Kurata, Ken-ichi Shinoda, Kazuo Umetsu, Yoshiji Yamada, Yoshiharu Oshida, Yuzo Sato, Nobuyoshi Hattori, Yoshikuni Mizuno, Yasumichi Arai, Nobuyoshi Hirose, Shigeo Ohta, Osamu Ogawa, Yasushi Tanaka, Ryuzo Kawamori, Masayo Shamoto-Nagai, Wakako Maruyama, Hiroshi Shimokata, Ryota Suzuki, Hidetoshi Shismodaira.
    Mitochondrial Genome Variation in Eastern Asia and the peopling of Japan.
    Genome Res 2004;14:1832-1850.

  215. Yoshiyuki Mizushina, Tsuyoshi Tsuzuki, Takahiro Eitsuka, Teruo Miyazawa, Kanako Kobayashi, Hiroshi Ikawa, Isoko Kuriyama, Yuko Yonezawa, Masaharu Takemura, Hiromi Yoshida, Kengo Sakaguchi.
    Inhibitory action of conjugated C18-fatty acids on DNA polymerases and DNA topoisomerases.
    Lipids 2004;39:977-983.

  216. Yoshiyuki Mizushina, N. Kasai, K. Miura, Shinya Hanashima, Masaharu Takemura, Hiromi Yoshida, Fumio Sugawara, Kengo Sakaguchi.
    Structural relationship of lithocholic acid derivatives binding to the N-terminal 8 kDa domain of DNA polymerase β.
    Biochemistry 2004;43:10669-10677.

  217. Yosuke Murase, Yoshiji Yamada, Akihiro Hirashiki, Sahoko Ichihara, Hirofumi Kanda, Masato Watarai, Fumimaro Takatsu, Toyoaki Murohara, Mitsuhiro Yokota.
    Genetic risk and gene-environmental interaction in coronary artery spasm in Japanese men and women.
    Eur Heart J 2004;25:970-977.

  218. Hideki Horibe, Yoshiji Yamada, Sahoko Ichihara, Masato Watarai, Masanobu Yanase, Kenji Takemoto, Seiji Shimizu, Hideo Izawa, Fumimaro Takatsu, Mitsuhiro Yokota.
    Genetic risk for restenosis after coronary balloon angioplasty.
    Atherosclerosis 2004;174:181-187.

  219. Katsumasa Takagi, Yoshiji Yamada, Jian-Sheng Gong, Takahito Sone, Mitsuhiro Yokota, Masashi Tanaka.
    Association of a 5178C→A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals.
    Atherosclerosis 2004;175:281-286.

  220. Yoshiji Yamada, Sahoko Ichihara, Hideo Izawa, Masashi Tanaka, Mitsuhiro Yokota.
    Genetic risk for coronary artery disease in individuals with or without type 2 diabetes.
    Mol Genet Metab 2004; 81: 282-290.

  221. Keiko Shimokata, Yoshiji Yamada, Takahisa Kondo, Sahoko Ichihara,Hideo Izawa, Kohzo Nagata, Toyoaki Murohara, Miyoshi Ohno, Mitsuhiro Yokota.
    Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia.
    Atherosclerosis 2004;172:167-173.

  222. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata.
    Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men.
    Metabolism 2004;53:135-137.

  223. -2003-
  224. Kohzo Nagata, Koji Obata, Mari Odashima, Akira Yamada, Fuji Somura, Takao Nishizawa, Sahoko Ichihara, Hideo Izawa, Mitsunori Iwase, Akemi Hayakawa, Toyoaki Murohara, Mitsuhiro Yokota.
    Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect.
    J Mol Cell Cardiol 2003; 35:1505-1512.

  225. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata.
    Association of a polymorphism of the dopamine receptor D4 gene with bone mineral density in Japanese men.
    J Hum Genet 2003;48:629-633.

  226. Yoshiyuki Mizushina, Naoki Maeda, Miho Kawasaki, Hideki Ichikawa, Chikako Murakami, Masaharu Takemura, Xianai Xu, Fumio Sugawara, Yoshinobu Fukumori, Hiromi Yoshida, Kengo Sakaguchi.
    The inhibitory action of emulsified sulfoquinovosyl acylglycerol on the mammalian DNA polymerases.
    Lipids 2003;38:1065-1074.

  227. Yoshiyuki Mizushina, Xianai Xu, Kiminori Matsubara, Chikako Murakami, Isoko Kuriyama, Masahiko Oshige, Masaharu Takemura, Norihisa Kato, Hiromi Yoshida and Kengo Sakaguchi.
    Pyridoxal 5'-phosphate is a selective inhibitor in vivo of DNA polymerase α and ε.
    Biochem Biophys Res Commun 2003;312:1025-1032.

  228. Yoshiyuki Mizushina, Mitsuru Hirota, Chikako Murakami, Tomomi Ishidoh, Shinji Kamisuki, Noriko Shimazaki, Masaharu Takemura, Marinela Perpelescu, Motoshi Suzuki, Hiromi Yoshida, Fumio Sugawara, Osamu Koiwai, Kengo Sakaguchi.
    Some anti-chronic inflammatory compounds are DNA polymerase λ-specific inhibitors.
    Biochem Pharmacol 2003;66:1935-1944.

  229. Chikako Murakami, Masaharu Takemura, Hiromi Yoshida, Fumio Sugawara, Kengo Sakaguchi, Yoshiyuki Mizushina.
    Analysis of cell cycle regulation by 1-mono-O-acyl-3-O-(α-D-sulfoquinovosyl)-glyceride (SQMG), an inhibitor of eukaryotic DNA polymerases.
    Biochem Pharmacol 2003;66:541-550.

  230. Yoshiyuki Mizushina, Xianai Xu, Chikako Murakami, Toshio Okano, Masaharu Takemura, Hiromi Yoshida, Kengo Sakaguchi.
    Selective inhibition of vitamin D2 and D3 on mammalian DNA polymerase α activity.
    J Pharmacol Sci 2003;92:283-290.

  231. Yoshiyuki Mizushina, Xianai Xu, Naoki Asano, Nobuyuki Kasai, Atsushi Kato, Masaharu Takemura, Hitomi Asahara, Stuart Linn, Fumio Sugawara, Hiromi Yoshida, Kengo Sakaguchi.
    The inhibitory action of pyrrolidine alkaloid, 1,4-dideoxy-1,4-imino-D-ribitol, on eukaryotic DNA polymerases.
    Biochem Biophys Res Commun 2003;304:78-85.

  232. Yoshiyuki Mizushina, Chikako Murakami, Kentaro Yogi, Katsuhiro Ueda, Tomomi Ishidoh, Masaharu Takemura, Marinela Perpelescu, Motoshi Suzuki, Masahiko Oshige, Toyofumi Yamaguchi, Mineo Saneyoshi, Hiromi Yoshida, Kengo Sakaguchi.
    Kohamaic acid A, a novel sesterterpenic acid, inhibits activities of DNA polymerases from deuterostomes.
    Biochim Biophys Acta 2003;1648:55-61.

  233. Miho Furuta, Katsura Nozawa, Masaharu Takemura, Shunji Izuta, Takashi Murate, Masayuki Tsuchiya, Kenji Yoshida, Naoki Taka, Yuji Nimura, Shonen Yoshida.
    A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
    Int J Cancer 2003;104:709-715.

  234. Yoshiyuki Mizushina, Tomomi Ishidoh, Shinji Kamisuki, Satoshi Nakazawa, Masaharu Takemura, Fumio Sugawara, Hiromi Yoshida, Kengo Sakaguchi.
    Flavonoid glycoside: a new inhibitor of eukaryotic DNA polymerase α and a new carrier for inhibitor-affinity chromatography.
    Biochem Biophys Res Commun 2003;301:480-487.

  235. Yoshiyuki Mizushina, Xianai Xu, Hitomi Asahara, Ryo Takeuchi, Masahiko Oshige, Noriko Shimazaki, Masaharu Takemura, Toshifumi Yamaguchi, Kazufumi Kuroda, Stuart Linn, Hiromi Yoshida, Osamu Koiwai, Mineo Saneyoshi, Fumio Sugawara, Kengo Sakaguchi.
    A sulfoquinovosyl diacylglycerol is a DNA polymerase ε inhibitor.
    Biochem J 2003;370:299-305.

  236. Chikako Murakami, Takayuki Yamazaki, Shinya Hanashima, Shunya Takahashi, Masaharu Takemura, Shonen Yoshida, Keisuke Ohta, Hiromi Yoshida, Fumio Sugawara, Kengo Sakaguchi, Yoshiyuki Mizushina.
    A novel DNA polymerase inhibitor and a potent apoptosis inducer: 2-mono-O-acyl-3-O-(α-D-sulfoquinovosyl)-glyceride with one stearic acid (α-SQMG-C18).
    Biochim Biophys Acta 2003;1645:72-80.

  237. Yoshiji Yamada, Nobuyuki Hamajima, Tomoyuki Kato, Hiroji Iwata, Yoshitaka Yamamura, Masayuki Shinoda, Motokazu Suyama, Tetsuya Mitsudomi, Kazuo Tajima, Suzuno Kusakabe, Hitoshi Yoshida, Yoshiko Banno, Yukihiro Akao, Masashi Tanaka, Yoshinori Nozawa.
    Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer.
    J Mol Med 2003;81:126-131.

  238. Hiroshi Noto, Masumi Hara, Ken Karasawa, Naoyuki Iso-o, Hiroaki Satoh, Masako Togo, Yoshiaki Hashimoto, Yoshiji Yamada, Tetsuya Kosaka, Mitsunobu Kawamura, Satoshi Kimura, Kazuhisa Tsukamoto.
    Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Arterioscler Thromb Vasc Biol 2003;23:829-835.

  239. Hideo Izawa, Yoshiji Yamada, Taro Okada, Masashi Tanaka, Haruo Hirayama, Mitsuhiro Yokota.
    Prediction of genetic risk for hypertension.
    Hypertension 2003;41:1035-1040.

  240. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata.
    Association of polymorphisms in the interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men.
    J Clin Endocrinol Metab 2003;88:3372-3378.

  241. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Hiroshi Shimokata.
    Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.
    Mol Genet Metab 2003;80:344-349.

  242. Akihiro Hirashiki, Yoshiji Yamada, Yosuke Murase, Yoriyasu Suzuki, Hiroki Kataoka, Yasutsugu Morimoto, Toru Tajika, Hirofumi Kanda, Hitoshi Ishihara, Mitsuhiro Yokota.
    Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors.
    J Am Coll Cardiol 2003;42:1429-1437.

  243. Yoshiji Yamada, Fujiko Ando, Naoakira Niino, Tetsuro Miki, Hiroshi Shimokata.
    Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese.
    J Hum Genet 2003;48:469-475.

ここから総説その他2.総説その他

    -2017-
  1. 山田芳司:
    冠動脈疾患の遺伝要因
    動脈・静脈の疾患(上)−最新の診断・治療動向−2017;75:93-97.

  2. 山田芳司:
    脳血管障害 最新多因子遺伝性疾患研究と遺伝カウンセリング
    遺伝子医学MOOK別冊 メディカルドゥ (印刷中)

  3. Yoshiji Yamada, Yoshiki Yasucochi.
    Genetics of coronary artery disease.
    In Dhavendra Kumar, Perry Elliot, eds. Principle and Practice of Clinical Cardiovascular Genetics. New York: Oxford University Press; 2017 (in press).

  4. Yoshiji Yamada, Ichiro Takeuchi, Koji Tsuda, Noboru Kunihiro, Jun Sakuma.
    Genetic epidemiology of cardiovascular disease and its application to personalized prevention.
    Fundamentals and Applicatins of Predictive, Preventive and Personalized Medicine. Moscow, 2017 (in press)

  5. -2015-
  6. 安河内彦輝:
    ヒトの遺伝【自然選択,霊長類】
    人間科学の百科事典(日本生理人類学会編)丸善出版 第1章(pp22-26)

  7. Maria Studneva, Mark Mandrik, Sihong Song, Evgeniya Tretyak, Ivan Krasnyuk, Yoshiji Yamada, Aleksandr Tukavin, Afaf Ansari, Ivan Kozlov, Chris Reading, Yinfa Ma, Kurt Krapfenbauer, Andrey Svistunov, Sergey Suchkov.
    Strategic aspects of higher education reform to cultivate specialists in diagnostic and biopharma industry as applicable to Predictive, Preventive and Personalized Medicine as the Medicine of the Future.
    EPMA J 2015;6:18.

  8. 山田芳司:
    血栓症の分子疫学とSNPs 新・血栓止血血管学―血栓症と出血病の症例を救命するために
    丸山征郎、一瀬白帝、内山真一郎、家子正裕、和田英夫、村田 満 編集
    金芳堂 (印刷中)

  9. Yoshiji Yamada.
    Molecular genetics of coronary artery disease and ischemic stroke.
    Personalized Medicine Universe 2015;4:4-12.

  10. 村方好子、藤巻哲夫、山田芳司:
    生活習慣が肥満・高血圧・2型糖尿病・脂質異常症に及ぼす影響:いなべ健康長寿研究のアンケート調査による検討
    臨床と研究 2015;92:615-624.

  11. Yoshiji Yamada.
    Genetics and genomics of osteoporosis and related disorders.
    In Dhavendra Kumar, Charis Eng, eds. Genomic Medicine:Priciple and Practice, Second Edition. New York: Oxford University Press;P352-368, 2015

  12. -2014-
  13. 山田芳司:
    遺伝子多型
    最新臨床脳卒中学(上)-最新の診断と治療- V.危険因子 2014;72 Suppl 5:302-305.

  14. 山田芳司:
    脳血管障害のオーダーメイド医療の展望
    分子脳血管病 特集II「脳卒中と遺伝子Update」 2014;13:33-37.

  15. -2012-
  16. Yoshiji Yamada.
    Molecular genetics of stroke.
    In Dhavendra Kumar, ed. Genomic and molecular medicine. Princeton: Morgan & Claypool Life Sciences (published online)

  17. -2011-
  18. Yoshiji Yamada.
    Author Interviews from Hemodialysis.com. Dr. Yamada: Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals.
    Hemodialysis.com (http://www.hemodialysis.com/), published online on June 13, 2011.

  19. Sahoko Ichihara.
    Role of AHR in the development of the liver and blood vessels.
    The AH receptor in biology and toxicology. Edited by Raimo Pohjanvirta, John Wiley & Sons, Inc. 2011;413-422.

  20. 山田芳司:
    個別化医療:総論 メディカルサイエンス遺伝子検査学
    近代出版 p173-174, 2012.

  21. Yoshiji Yamada,Sahoko Ichihara,Tamotsu Nishida.
    Genome-wide association studies of coronary heart disease.
    In Ion Tintoiu, Alain Rivard, Florina Pinte, Cristian Gabriel, Evelyn Regar, eds. Coronary stent restenosis. Bucharest: Romania Medical Academy Press; P329-340, 2011.

  22. -2010-
  23. 山田芳司:
    分子遺伝疫学を用いた疾病のリスク評価と予防
    公衆衛生 2010;74:761-767.

  24. Yoshiji Yamada.
    Molecular genetics of myocardial infarction.
    Encyclopedia of Life Sciences (http://www.els.net/), published online on February 15, 2010.

  25. Yoshiji Yamada, Sahoko Ichihara, Tamotsu Nishida.
    Genetics of coronary heart disease.
    In Dhavendra Kumar, Perry Elliot, eds. Clinical Cardiovascular Genetics: Principle and Practice. New York: Oxford University Press; P315-328, 2010.

  26. Yoshiji Yamada, Sahoko Ichihara, Tamotsu Nishida.
    Stroke.
    In Dhavendra Kumar, Perry Elliot, eds. Clinical Cardiovascular Genetics: Principle and Practice. New York: Oxford University Press; P337-350, 2010.

  27. -2009-
  28. 山田芳司:
    脳卒中の危険因子-遺伝要因
    臨床と研究 2009;86:27-32.

  29. 山田芳司
    心筋梗塞のゲノム疫学
    循環器専門医 2009;17:55-61.

  30. -2008-
  31. Yoshiji Yamada, Sahoko Ichihara, Tamotsu Nishida.
    Proinflammatory gene polymorphisms and ischemic stroke.
    Curr Pharm Des 2008;14:3590-3600.

  32. Yoshiji Yamada.
    Osteoporosis and related phenotypes.
    Genomics and Clinical Medicine, Dhavendra Kumar, editor, Oxford University Press, New York 2008;p529-543.

  33. Yoshiji Yamada, Sahoko Ichihara, Masaharu Takemura.
    Human functional genomics and proteomics.
    Genomics and Clinical Medicine, Dhavendra Kumar, editor, Oxford University Press, New York 2008;p31-43.

  34. Sahoko Ichihara, Yoshiji Yamada.
    Genetics factors for human obesity.
    Cell Mol Life Sci 2008;65:1086-1098.

  35. Yoshiji Yamada, Sahoko Ichihara, Tamotsu Nishida.
    Molecular genetics of myocardial infarction.
    Genomic Med 2008;2:7-22.

  36. Yoshiji Yamada.
    Editorial commentary: The electronic health recored as a primary source of clinical phenotype for genetic epidemiological studies.
    Genomic Med 2008;2:5.

  37. 山田芳司
    遺伝子による心筋梗塞リスクの評価
    Annual Review循環器2008
    山口 徹、高本眞一、中澤 誠、小室一成編集 中外医学社 2008;p42-50.

  38. 山田芳司
    遺伝子多型の統計学的解析法
    図説 分子病態学 改訂第4版
    一瀬伯帝、鈴木宏治編集 中外医学社 2008;p182-185.

  39. 山田芳司
    生活習慣病のゲノム疫学 (3):心筋梗塞のオーダーメイド予防
    現代医学 2008;55:549-559.

  40. -2007-
  41. 山田芳司
    身近になった遺伝子検査〜生活習慣病をチェックするジェノマーカー
    LongLife 2007;8:13-15.

  42. 山田芳司
    脳血管障害のオーダーメイド予防
    脳神経外科速報 2007;17:1320-1329.

  43. 山田芳司
    脳血管障害のゲノム疫学とオーダーメイド予防
    脳卒中 2007;29:715-720.

  44. 山田芳司
    生活習慣病のゲノム疫学 (2):脳血管障害のオーダーメイド予防
    現代医学 2007;55:335-343.

  45. 山田芳司
    生活習慣病のゲノム疫学 (1):生活習慣病のオーダーメイド予防システムの開発
    現代医学 2007;55:153-157.

  46. -2006-
  47. 山田芳司
    循環器疾患の遺伝要因の解明と遺伝子リスク診断システムの開発
    心臓 2006;38:1159.

  48. 山田芳司
    心筋梗塞・脳血管障害のオーダーメイド予防システムの開発
    心臓 2006;38:1175-1180.

  49. 市原佐保子、横田充弘:
    生活習慣病(糖尿病、高脂血症)
    バイオ解析・診断技術のテーラーメイド医療への応用
    山本重夫監修 シーエムシー出版 p87-98, 2006

  50. 山田芳司
    ゲノム多型による脳血管障害の発症予測
    バイオ解析・診断技術のテーラーメイド医療への応用
    山本重夫監修 シーエムシー出版 p110-118, 2006

  51. Yoshiji Yamada.
    Identification of genetic factors and development of genetic risk diagnosis systems for cardiovascular diseases and stroke.
    Circ J 2006;70:1240-1248.

  52. -2005-
  53. Yoshiji Yamada.
    Book review: Genetic Disorders of the Indian Subcontinent.
    J Med Genet 2005;43:288.

  54. -2004-
  55. Akihiro Hirashiki, Yoshiji Yamada, Mitsuhiro Yokota.
    Association of gene polymorphisms with coronary artery disease.
    J Am Coll Cardiol 2004;44:209-210.

  56. 井澤英夫、山田芳司、岡田太郎、田中正嗣、平山治雄、室原豊明、横田充弘:
    高血圧症の遺伝的リスク診断
    J Cardiol 2004;43:92-93.

  57. 山田芳司
    PAI-1とは?
    肥満と糖尿病 2004;3:774-775.

  58. -2003-
  59. Yoshiji Yamada, Mitsuhiro Yokota.
    Risk of myocardial infarction and polymorphisms in candidate genes.
    N Engl J Med 2003;348:1176-1177.

  60. Yoshiji Yamada.
    Molecular genetics and epidemiology of osteoporosis.
    Curr Pharmacogenomics 2003;1:139-149.

  61. 山田芳司、横田充弘:
    心筋梗塞のリスク遺伝子.
    総合臨床 2003;52:1428-1434.

  62. 山田芳司、横田充弘:
    遺伝子多型による心筋梗塞危険度の予測.
    実験医学 2003;21:1258-1262.